Results 61 to 70 of about 1,545,378 (246)

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Um estudo das formas de contabilização dos recursos econômico-financeiros em entidades sem fins lucrativos não gonervamentais [PDF]

open access: yes, 2001
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro Sócio-EconômicoAs entidades sem fins lucrativos não governamentais são formadas pela sociedade civil e surgem para suprir as deficiências do Estado ou para desempenhar atividades ...
Jeremias, Cristiane
core  

SEM-EDS results (wt%) of glassy matrix analyses.

open access: yes, 2021
SEM-EDS results (wt%) of glassy matrix analyses.
Ignacio Montero-Ruiz (6576902)   +4 more
core   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

SEM-EDS results (wt%) of bulk ceramic analyses.

open access: yes, 2021
SEM-EDS results (wt%) of bulk ceramic analyses.
Ignacio Montero-Ruiz (6576902)   +4 more
core   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Música quase sem compositor

open access: yes, 2012
Steve questiona a composição musical de maneira radical: ele quer uma música que seja criada sem um compositor, ou quase istoEnsino Médio ...
Rocha de Oliveira, Samuel   +4 more
core   +2 more sources

SEM of crust

open access: yes, 2002
Image Type: SEM Image, Scale Bar: 200um, Magnification: 170, Etch: No etching, Coating: Au/Pd, Instrument Location: UNM, Scan: med, Spot Sz ...
Melim, L., Spilde, M., Northup, D.
core  

Gerência da largura de banda para garantir QoS adaptável em redes sem fio ad hoc [PDF]

open access: yes, 2001
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro Tecnológico.As redes sem fio apresentam um novo paradigma computacional que tem como função principal prover aos usuários o acesso permanente à rede independente de sua localização ...
Lima, Abiel Roche
core  

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy